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Abstract We recently showed that a karyophilic protein forms 
a stable complex, termed nuclear pore-targeting complex 
(PTAC), with cytoplasmic components prior to nuclear pore- 
binding. In this study, we cloned a cDNA encoding a 97 kDa of 
PTAC (PTAC97). Recombinant PTAC97 completely reconsti- 
tutes the nuclear binding-step in conjunction with a 58 kDa com- 
ponent of PTAC (PTAC58) in the semi-intact cell-free transport 
assay. Biochemical analysis reveals that PTAC58 binds to a 
karyophilic protein, and PTAC97 is associated with PTAC58 in 
a 1:1 molar ratio. A complex of PTAC97 and PTAC58 targets 
nuclear pores, depending on the presence of a karyophile. These 
in vitro results suggest hat the first step in nuclear import occurs 
through the targeting-complex formation of a karyophile with 
PTAC58 bound to PTAC97. 
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1. Introduction 
The selective nuclear import of karyophilic proteins is di- 
rected by short amino acid sequences termed nuclear location 
signals (NLSs) [1]. The process of mediated import can be 
essentially divided into two steps, an ATP-independent binding 
to the cytoplasmic face of nuclear pores, and the subsequent 
ATP-dependent translocation through the nuclear pore com- 
plex (NPC) [24]. Using a semi-intact cell-free transport assay, 
we recently demonstrated that an SV40 T-antigen NLS contain- 
ing karyophile forms a stable complex with cytoplasmic compo- 
nents for nuclear pore-targeting [5]. The complex, termed nu- 
clear pore-targeting complex (PTAC), contained two essential 
proteins having masses of 54 and 90 kDa, respectively, as esti- 
mated by electrophoresis. The 54 kDa component, termed 
PTAC58 (designated based on the calculated molecular mass 
of 58 kDa deduced from cDNA sequence ncoding this pro- 
tein), was found to be the mouse homologue of a 60 kDa 
subunit of Xenopus importin [6,7]. In this study, we have 
cloned, sequenced, and expressed a cDNA encoding the 90 kDa 
component of PTAC (designated PTAC97). Using the recombi- 
nant proteins, we provide in vitro evidence that the first-step 
in nuclear import occurs through the targeting complex forma- 
tion of a karyophile with PTAC58 bound to PTAC97. 
*Corresponding author. Fax: (81) (6) 879 3219. 
**These two authors contributed equally to this work. 
2. Materials and methods 
2.1. cDNA cloning 
Lysyl endopeptidase-digested peptides of the 90 kDa protein excised 
from an SDS-PAGE gel were used to obtain internal amino acid se- 
quences [8]. Two of the four sequences determined by peptide sequenc- 
ing were used to obtain partial cDNA fragments of the 90 kDa protein 
using polymerase chain reaction (PCR) procedures. Four degenerated 
oligonucleotides were synthesized corresponding to the sense and anti- 
sense sequences of the two peptides, NPDWRYRD and TLATWATK. 
The template for PCR was cDNA synthesized from mRNA prepared 
from mouse Ehrlich ascites tumor cells using Ready-To-Go cDNA 
synthesis kit (Pharmacia Biotech). A 1.5 kbp fragment was amplified 
in one of the two combination of the sense and antisense primers. 
Sequencing of both ends of the fragment revealed the existence of the 
amino acid sequences determined by peptide sequencing franking the 
primers, indicating that the fragment was a partial-length cDNA of the 
90 kDa protein. This fragment was used to screen a mouse cDNA 
library in Agtl0 (approx. 1.5 x 10 6 pfu). 50 clones were isolated and 
analyzed by PCR and restriction mapping. Two overlapping clones #4 
and #33 covered a full-length 90 kDa protein cDNA. 1.8 kbp and 2.1 
kbp EcoRI fragments composing the full-length were cut out from 
DNA of clones #4 and #33, and subcloned into pUC119 and pGEMZf 
(-), respectively. The resultant plasmids were designated p4L2 and 
pN33, respectively. The inserts were sequenced by the dideoxy chain 
termination method using an automated cDNA sequencer (LI-COR 
Model 4000L) and Sequitherm (Epicentre Technologies). 
The DNA and deduced amino acid sequences were compared to the 
GSDB, DDBJ, EMBL and NCBI database using the BLAST pro- 
grams. The cloned cDNA showed 62% amino acid similarity and 38% 
identity with yeast L8300 15 (ACC U19028), 98% with a 90 kDa subunit 
of human importin (ACC L38951), and 99% with rat karyopherin beta 
(ACC L38644). 
2.2. Recombinant expression a d purification 
An epitope-tagged PTAC97 was constructed in a glutathione-S- 
transferase (GST) gene fusion vector pGEX-2T. A tag encoding an 
influenza virus hemagglutinin (HA) epitope with BamHI and SacI sites 
at the ends was generated by annealing of two synthetic oligonucleo- 
tides with the sequences 5'-GATCCTACCCATACGACGTCCCA- 
GATTACGCTAGCGGTATGGAGCT-3' and 3'-GATGGGTATG- 
CTGCAGGGTCTAATGCGATCGCCATACC-5'. This tag, the 
SacI-EcoRI fragment corresponding toresidues 2-642 from pN33 and 
EcoRI-KpnI fragment containing a partial-length cDNA correspond- 
ing to residues 643-876 from p4L2, were subcloned into pBluescript 
SK(-) and the resulting plasmid was sequenced toconfirm the fidelity 
of the oligonucleotide insert. A BamHI-KpnI fragment assembled from 
the three fragments was excised and inserted into the BamHI and KpnI 
sites of a modified pGEX-2T in which KpnI site was introduced at the 
EcoRI site by linker ligation. The construct was called pGEX HA- 
PTAC97 and was used for the expression of the GST fusion protein in 
E. coli. The plasmid expressing a full-length PTAC97 fused to GST 
without HA tag was constructed from pGEX HA-PTAC97 by cutting 
out the BamH~SacI fragment corresponding to the HA epitope fol- 
lowed by blunting and ligation. The resultant plasmid pGEX PTAC97 
was sequenced to confirm in-frame ligation of the fused region. The 
expression of the recombinant PTAC97 fusion proteins was induced by 
1 mM isopropyl-l~-D-thiogalactopyranoside (IPTG) for 14 h at 20°C. 
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E. coli cells expressing the fusion proteins were disrupted using a french 
press, and the fusion proteins were purified from the lysates using 
glutathione-Sepharose (Pharmacia) affinity chromatography. Recom- 
binant PTAC97, obtained after cleavage of the GST portion with 
thrombin, co-migrated with the authentic 90 kDa component of the 
nuclear pore-targeting complex. The activity of recombinant PTAC97 
was not affected by the presence of the GST portion, nor modification 
by epitope tagging when examined in the digitonin-permeabilized cell 
free transport assay. 
Recombinant PTAC58 was expressed in E. coli strain BL21 as GST- 
fusion protein by induction of lmM IPTG for 14 h at 20°C. The fusion 
protein was purified from the E. eoli lysate by glutathione affinity 
chromatography. 
2.3. Cell-free import assay 
Digitonin permeabilized Ptk2 cells were prepared as described previ- 
ously [5]. Ten ,ul testing solutions constitutively contained 6 pmol of 
T-bBSA (unless indicated), 60 pmol of mutantT-BSA, 10% BSA and 
transport buffer (20 mM HEPES pH 7.3, 110 mM potassium acetate, 
2 mM magnesium acetate, 5 mM sodium acetate, 0.5 mM ethylene 
• ~ ,'q'TACAGTCTATTAAAAT 
i. 9 T~'AC~-'CCTAAAA,~O3GAC~GC~.~Tt-3GCCAGAGGCACaYCGG2~kA " " . CCC 
9 C ~AC C CC CCACCCCACCCTCCLTPCCCACCCCqAACCCCAACCCCCATCCCCAGTCC~ 
l 39 C OCCC<~C ~ACAGGC CGGGC C~ C G T C ~ ~  CCCC, CCC<'CGTCACCTC GCC 
199 ATC~C,~TAACCATCC~.~GAAC*ACC~TCTCCGC,  A - . 
M E L i T I L E K T V S P D R L E L E A 20 
2 59 GCGCAGAAGTTCCTCGAC~CGTC~TC~CCACGTTCC~CTG 
A ,2 K F L E R A A V E N L P T F L V E L 40 
3 l 9 TCCAGAG . ~ C C C A C ~ C / ~ C A ~ G q ~ C A C ~ A C _ A A  
S R V L A N P G N S Q V A R V A A G L Q 60 
3 "79 A%?TAAGAAC' I~TCGAAAC,  ATCCAGATATCAAC~CAATACCAC~ 
K N S L T S K D P D I K A Q Y Q Q R W 80 
439 ~ .C'PCCJCTA .'~IXIATGCTAATC, CTCGACC~GT~CTA~a- I -  f~l "I~_,CAC, ACGT~ 
,.L A I D A N A R R E V K N Y V L Q T L G I00 
499 ACAC, AAACGTACCGC, CCTAGTTCGGCCTCACA~A _GAG 
T E T Y R P S S A S Q C V A G I A C A E 120 
559 A%~CCC_AGTAAGCCA~CAGAC,  CTAA'~C~AC-CCAATGTCACAAACCCC 
[ P V S Q W P E L I P Q L V A N V T N P 140 
619 AACAOCACAGAGCATA2X~GTCCACATTC,  GAAGCTAT '~ACA'~CAAGAT 
N S T E H M K E S T L E A I G Y I C Q D 160 
679 AT AGAC C CAC, AC-CAGCTACAGC, ATAAGTCCAATC~.GATCCTC~AC~CATAATCCAC~ 
I D P E Q L Q D K S N E I L T A I I Q G 180 
739 ATCaAGC~AAC~ C 'TAGTAACAAq~'TC~ACCAATC~ C T ~  
M R K E E P S N N V K L A A T N A L L N 200 
799 .~CACTAGAGTTCACCAAAGCAAACTTTGACAAAGA~C~ATCATGCAA 
S L E F T K A N F D K E S E R H ~ I M Q 220 
59 G TGG ~"~C~C CAC-ACAGq~GTC -AC=ACACAAGC~ A.%C,A~AC_AC~T 
'~ V C E A T Q C P D T R V R V A A L Q N 240 
919 CTAGTGAAGATAATGTCC~ATTACCAGTACATGGAGACATACATGGGTCC' I~3CCC~ 
L V K I M S L Y Y Q Y M E T Y M G P A L 260 
979 TTTGCAATCACAA? IC~AAGCAATGAAAAG~CA~CPGATGAC~GGGATA 
F A I T ! E A M K S D I D E V A L Q G I 280 
i 039 GAG"~' t 'TGGTCCAATGTCTGTGATGAGGAAATC~ATTTO3CCATTGA~~ 
E F W S N V C D E E M D L A I E A S E A 300 
i 099 ~.-AGAGCAAGGACC, C C CC CC~C, AC, CACACCAGCAAATI' I~ACGC A A ~ ~  
A E Q G R P P E H T S K F Y A K G A L Q 320 
1159 TACT~TGC C CATC CTCACACAGACACq~ACTAAACAGGATGA~CC,  ATCaACGACGAT 
Y L V P I L T Q T L T K Q D E N D D D D 340 
! 219 GACICGAACCCq~[~-AAAGCA~CIX~ATGC' I~CTGTCCAC~ 
D W N P C K A A G V C L M L L S T C C E 360 
1279 GATGACA~PG ."~GC CGCATGTCC~CC~A'~FAA~CATCAAGAACCCI~ 
D D I V P H V L P F I K E H I K N P D W 380 
1339 CGATAC C C ~ T G C A G C A G T ~ T C ~ A G T A T C ' ~ C ~ C T A A T  
R Y R D A A V M A F G S I L E G P E P N 400 
1399 CAACTGAAACCATTAGTCATACAGGCTATC, C CACC CTAATAC, AACTAATGA~CCC 
Q L K P L V I Q A M p T L I E L M K D P 420 
1459 AG TG TAG TTG q'~C GAC, AC ACAACAC~C~ TC~AGC,  ATC~ TCaAC, CTC~ CT 
S V V V R D T T A W T V G R I C E L L P 440 
1519 GAAGC CGCCATCAACGATGTC'TACC~CCCC~ACAGT~TT~CTC 
E A A I N D V Y L A P L L Q C L I E G L 460 
1579 AGTC~AC,  C C C A C ~ T G " f ~ V f "  1" I-IC _GCT 
$ A E P R V A S N V C W A F S S L A E A 480 
1639 GCGTATGAAC~GAq~TAC~T~IA~CAAC*AAC,  AACCA~CACCTA~f f I~  
A Y E A A D V A D D Q E E P A T Y C L S 5(}0 
1699 TCTTC C~C' IT  AT A ~ G A A C ~ A T ' ~  C AC CGACAGAC CC, ATGC, ACAC 
S S F E L I V Q K L L E T T D R P D G H 520 
1759 C AGAAT AAC CTGAGAAC~ GTATG~GTCTCTC ATGGAAATCGTAAAGAAC AGTC, C C 
Q N N L R S S A Y E S L M E I V K N S A 540 
1819 AAGGA~ZPGTTAC CCTGCCGTC~CCACCCTC~ATTATGGAACGGCTGCAC,  CAG 
K D C Y P A V Q K T T L V I M E R L Q Q 560 
1879 GTC~AGATC~CCATATCCAGAGCACATCCGACAC*AATCCA~CaACC~ 
V L Q M E S H I Q S T S D R I Q F N D L 580 
1939 CAGTCTCTACTCTCaCGCGACTC~AGAAT~CGGAAAGTC~TCAAGATGCT 
Q S L L C A T L Q N V L R K V Q H Q D A 600 
1999 CTC, C A G A T C ~ T ~ T G G C  CTC C CTG TTAAGGATG~ C A A A C ~ C ~  
L Q I S D V V M A S L L R M F Q S T A G 620 
glycol bis (fl-aminoethylether)-N,N,N',N'-tetraacefic acid (EGTA), 
2 mM DTT and 1 gg/lnl each of aprotinin, leupepfin, and pepstatin). 
Transport assays were performed in the presence of either or both 
recombinant PTAC58 and PTAC97 proteins at amounts indicated in 
the respective figure l gends, with or without competitor proteins. After 
incubation, cells were fixed, and stained with fluorescein isothiocyanate 
(FITC)-labeled Avidin (Pierce) to visualize the localization of T-bBSA 
as described previously [5]. 
2.4. Transport substrates 
Bovine serum albumin (BSA) (Sigma), biotinylated BSA [5], or allo- 
phycocyanin (APC)(Calbiochem) was chemically conjugated to syn- 
thetic pepfides containing wild-type (T-peptide: CYGGPKKKRKVE- 
DP), point-mutated (mutant T-pepfide: CYGGPKTKRKVEDP), or 
reverse (reverse T-peptide: CYGGPDEVKRKKKP) sequence of SV40 
T-antigen NLS as described previously [9]. All conjugates contained 
10-15 peptides per carrier molecule (analyzed by SDS-PAGE). 
2.5• Antibodies 
Anfi-HA monoclonal antibody 12CA5 [10] was purchased from 
2059 TCTC~TC,  CAAC, AAGA q3C, C C ;J~. ~A~C, CA G T'T AGC AC A CL:~93 -'~3GAAG .'?'] ~Y;3T  
S G G V Q E D A L M A V S T L V 3 • G L £4~ 
2119 GGTC, AATTCC~ AAGTACATGGAGGC C~AAACCAT'U-"  ~ ,CT~C~3CA -'Z:~. f~ACq~T 
E V L G G E F L K Y M E A F K P F L K N 66~ 
2 ! 79 TATC-C~AC C ~  ATGI" rq~AC~.  ~%~.~. .  AGT~. .aC~C'~. .4~ C GAC~T C 
Y A E Y Q V c L A A V G L V G D L 'T ~ A 6~6 
2239 C T C ~ A A C A T C ~  CTTT~TC,  ACC, AC~TGC~CqV- .  ~C.AGAA ,C~.  ~ 
L Q s N I L P F C D E V M Q L L L E N L "~3 
2299 C~TGAGAATGTCCACAC~TGAAGC CACAGATT~TC~. ,GTC,  ATATT 
G N E N V H R S V K P Q I L S V F G D i ~Z~ 
2359 GC~TTC~GTTTAAAAAATAC~AC.AGGTTGTAT~,  ~.AATACTCTACAG 
A L A I G G E F K K Y L E V V L N T L Q 74~ 
2419 CAC, C, CC~CCA~CCAC~CAAG'TC-AGAC~CATC~q'FATC~TGAG 
Q A S Q A Q V D K S D F D M V D Y L N E "63 
2479 CTAAC~ ATACGGGAATCGTCCAGGGAq'PGAAC, C, GAGATCAG 
L R E S C L E A Y T G I V Q G L K G D Q 7~ 
2539 GAAAACGTACACCCGGATGTAATGCTCK3TACAGCCCAGAGTAGAATTTAT' I~- I " :  T = 
E N V H P D V M L V Q P R V E F I L S F ~[3 
2599 ATTGA ?C AC A T '~GATC,  AGGATCATACC, GAC CqGAGTC, GT AGC ~TG ,'?2,CT~%I vC~5"T 
I D H I A G D E D H T D G V V A C A A G 82~ 
2659 CTGATAGGGGACTTG TGT ACAGCC'~GGGAAGGATGTACTC,  AAGq~AG T AGAAC~-  AGG 
L I G D L C T A F G K D V L K L V E A R @40 
2719 CCAATGATCCATGAACTATTAA~GGAGA~CGAAGACTAACAA~GACC 
P M I H E L L T E G R R S K T N K A K T 86G 
2779 CTCGCTACGTGC~C CAAGGAAC'PGAGGAAACTGAAGAACCAGC~ ~ATCT~ GTAC C 
L A T W A T K E L R K L K N Q A " 876 
28]9 AC~q~,ATC.AC CTCaAGACCCCC ACTC~AAATCTCCAA CCCC~G 
2899 T C ~  TGTGC_ACGGATC~TGC2~TGAGAGGATGA~G T C ~  
2959 AAACACCACACTC~TCCTGC CACAGCCAACAGCAGCAC, CGCTGTTAGACA2X3AGCTA 
3019 AGTAAGCACTGAG~' I~AGAAAACATAACATCAGC CATCTTC43AACAGAGAAACAATGG 
3079 ATT 'FACTTAC~Aq~fAAAAACA~.C~ CCAGGGAAGGCTAGAACTAGCT 
3139 TTCL '~ 'GTt~ C C ~  C GAA T C ~  CTGATT~GAGGAGGAC CTGGG~CAC 
3199 _ C ~ C C  C~ACTGAGGAGAA~ TC, GAGCC 
9259 C C ~ G C C  CACC~AC'PGTAACGT~CT~TACTGTCTA~GTGCCCTTC~/3  
3319 AAGC, C C ~ T C - A C A G ~ G A A T C a A ~ G ~ A C C C A C  
3379 A T T ~ A T T ~ G ~ x - ~ t  "t TI'~CCCAGAAAA - TGTT~ 
3439 CAT'PTCATAAACTAA AC~TGCAGCACAAGAGACGT~ t - ~- el- r~  
3499 TTAAAIX~GACC~'FFAGGTT~I" I~F Ik~A' I~AATTAC~AGGGAA 
3559 AACACTC~ACGAATGGTC-AGC~ CTC, ATCT~TCAAC~ C ~  C~ T A 
3619 CTATC~GCT~TGTAGCT ATGGC~C~GAAAC~CTCTC,  GAGT 
3679 TAGAC, C, ATATAGAAAATAAAAGTACAGTTGTTACAAAGAAAA TC, CAGACT~C AAAGAC AG 
3739 AAAAAGCCACAACCCAAACCAAAATTTAAA'PGCT~TTGGCATCATAAACAAGCT~ 
3799 C T C C ~ C ~ A T ~ G T C ~ T G C  CCCCAGAAAACTGTGC CAAAGAGTTTAGA 
3859 AAACAAATGTACAATAAAAGTAAATACACTCAAAACCGCAAAAAA~ 
Fig. I. Nucleotide and deduced amino acid sequence of a 90 kDa component of PTAC (DDBJ accession umber D45836). A cDNA library was 
screened with partial cDNA fragments obtained from PCR using degenerate oligonucleotides corresponding to determined amino acid sequences. 
Sequences obtained by peptide sequencing of the 90 kDa component are underlined. 
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Boehringer Mannheim. Anti-PTAC58 antibodies were affinity purified 
on recombinant PTAC58-Sepharose column from antisera of rabbits 
immunized with GST-PTAC58 fusion protein. 
3. Results and discussion 
In order to characterize the 90 kDa component of the nuclear 
PTAC, we first cloned the cDNA encoding this protein. Fig. 
1 shows the DNA sequence and its predicted amino acid se- 
quence (DNA Data Bank of Japan (DDBJ), accession umber 
D45836). The open reading frame encodes a polypeptide of 876 
amino acids with a calculated molecular mass of 97.2 kDa. The 
recombinant 90 kDa component was then expressed in E. coli, 
and its activity examined using a digitonin permeabilized cell- 
free transport assay [11]. Biotinylated bovine serum albumin, 
chemically coupled to a synthetic peptide containing the SV40 
T-antigen NLS (T-bBSA) was used as a transport substrate. As 
shown in Fig. 2, neither PTAC58 alone nor the recombinant 
90 kDa protein alone mediated efficient nuclear im-binding of 
T-bBSA. However, in the presence of both proteins, T-bBSA 
accumulated efficiently at the nuclear im. The rim-binding of 
T-bBSA was competitively inhibited in the presence of excess 
non-biotinylated T-BSA while the same amount of transport 
incompetent reverse sequence of SV40 T-antigen NLS [12] con- 
jugated BSA had no effect. The binding was not affected by 
incubation temperature, or, by either the absence or presence 
of ATE Under the same assay conditions, the nuclear entry of 
the substrate (homogeneous nuclear staining) was not observed 
even in the presence of ATP (data not shown). These results 
confirm that the recombinant 90 kDa protein, in conjunction 
with PTAC58, reconstitutes the NLS-dependent, and ATP- 
independent initial binding step of the transport. The maximal 
rim-binding of T-bBSA was achieved when the two compo- 
nents were present in equimolar concentration. Based on the 
activity of the recombinant protein and the molecular mass 
calculated from the predicted amino acid sequence, we desig- 
nate this protein PTAC97 (97 kDa component of PTAC) 
Using recombinant proteins, interactions involving T-bBSA, 
PTAC58, and PTAC97 were examined. For this, mixtures of 
T-bBSA/PTAC58, T-bBSA/PTAC97, PTAC58/PTAC97, or T- 
bBSA/PTAC58/PTAC97 were incubated, and complex forma- 
tion was examined by gel filtration chromatography. As shown 
in Fig. 3A, T-bBSA associates directly with PTAC58, but not 
with PTAC97. The association f T-bBSA with PTAC58 was 
found to be competitively inhibited by the presence of excess 
non-labeled T-BSA, while transport incompetent reverse or 
point-mutated SV40 T-antigen NLS conjugates had no effect 
[7]. PTAC97 Associates directly with PTAC58 in a 1 : 1 molar 
ratio, even in the absence ofT-bBSA (Fig. 3A and B). This was 
determined by adding increasing amounts of PTAC97 to con- 
stant amounts of PTAC58 and T-bBSA. As shown in Fig. 3B, 
the amount of PTAC97 incorporated in the targeting complex 
increased up to that equivalent to PTAC58, but did not lead 
to additional increases even in the presence of excess PTAC97. 
These data are consistent with a scenario wherein the targeting 
complex is formed through interactions of NLS with PTAC58 
which, in turn, is bound to equimolar PTAC97. Based on our 
recent observation that PTAC58 is located mainly in the cyto- 
plasm of mammalian cells [7], PTAC58 and PTAC97, in all 
probability exist as a complex in the cytoplasm. The PTAC58/ 
PTAC97 complex would be predicted to act as a cargo that 
carries NLS-containing proteins from cytoplasm to nuclear 
pores. 
In order to determine whether the complex of PTAC58/ 
PTAC97 binds to nuclear pores alone, or it targets nuclear 
pores only after association with karyophiles, the nuclear bind- 
ing activity of the PTAC58/PTAC97 complex was examined. 
In these experiments equimolar mixtures of recombinant 
PTAC58 and influenza virus hemagglutinin (HA) epitope- 
tagged PTAC97 proteins were incubated with semi-intact eils, 
either in the presence or absence of T-peptide conjugate. As 
shown in Fig. 3A, PTAC58 and PTAC97 form a complex even 
in the absence of the karyophile under these conditions. The 
PTAC58/PTAC97 complex did not accumulate at the nuclear 
rim in the absence of the karyophile (Fig. 4a), but did so effi- 
ciently in the presence of the karyophile (Fig. 4b,c). Punctated 
nuclear im staining was observed (Fig. 4c), which reflected the 
staining of nuclear pores as previously reported [13,14]. The 
data suggest hat complex formation of the karyophile with 
PTAC58 bound to PTAC97 is required for nuclear pore-bind- 
ing activity of PTAC. 
For the nuclear pore-binding of T-bBSA, both PTAC58 and 
PTAC97 were required. PTAC97 Associates directly with NLS- 
binding protein, PTAC58, but not with NLS-containing karyo- 
phile. To date, bovine NEM-sensitive 54/56 kDa NLS-binding 
protein [15], bovine p97 [16], importin which consists of a 60 
PTAC97 PTAC97 PTAC97 
PTAC97 PTAC58 +PTAC58 +PTAC58 +PTAC58 
+reverse-T +wild-T 
Fig. 2. Effect of recombinant 90kDa protein (PTAC97) on the nuclear-binding step of transport indigitonin-permeabilized cell-free transport system. 
Ptk2 Cells permeabilized with d gitouin were incubated with 10/.tl of test solution for 30 min on ice in the absence of an energy source. Incubation 
was performed in 10 ~1 of test solution, which ontained 6 pmol of T-bBSA, with or without recombinant PTAC58 or PTAC97 in the presence or 
absence of competitor p oteins. 'PTAC97' indicates th  presence of 12 pmol of recombinant PTAC97 protein and 'PTAC58' indicates the presence 
of 12 pmol of recombinant PTAC58 protein, 'reverse-T' and 'wild-T' indicate the presence of 60 pmol of competitor non-biotinylated BSA conjugates 
of reverse T-peptide and wild type T-peptide respectively. Localization of T-bBSA was visualized with FITC-Avidin. 
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PTAC97 
PTAC97 A 
PTAC97 + T-bBSA 
PTAC97 + PTAC58 




PTAC58 ÷ T-bBSA 
PTAC58 + PTAC97 
PTAC58 + T-bBSA + PTAC97 
16 17 18 19 20 21 22 23 24 25 26 
Superose fractions 
T-bBSA 
T-bBSA + PTAC97 
T-bBSA + PTAC58 
T-bBSA + PTAC97 + PTAC58 
1 2 
PTAC97 o. 16 
PTAC58 1.o 1.0 
3 4 5 6  B 
PTAC97 
~P-  PTAC58 
0.32 o.71 0.93 0.95 
1.0 1.0 1.0 1.0 
Fig. 3. PTAC97 associates directly with PTAC58 possessing NLS- binding activity. (A) T-bBSA incubated with equimolar PTAC58, HA- epitope 
tagged PTAC97, or both PTAC58 and HA-PTAC97, or HA- PTAC97 incubated with equimolar PTAC58 on ice for 1 h was subjected to gel filtration 
chromatography using a Superose 12 column equilibrated with transport buffer. Each Superose fraction was blotted onto nitrocellulose membrane 
and probed with anti-BSA antibodies, anti-PTAC58 antibodies, and anti-HA monoclonal ntibody 12CA5, to detect T-bBSA, PTAC58, and PTAC97 
respectively. The antibodies were detected with alkaline phosphatase-conjugated goat antibodies to rabbit IgG or mouse IgG (Bio-Rad) by the 
standard method. (B) T- bBSA trapped in Immobilized Avidin was incubated with 0 pmol (lane 1), 30 pmol (lane 2), 60 pmol (lane 3), 120 pmol 
(lane 4), 240 pmol (lane 5), and 480 pmol (lane 6) recombinant PTAC97 in the presence of 120 pmol recombinant PTAC58. After incubation (1 h 
at 4°C), proteins associated with T-bBSA were analyzed by SDS-PAGE. To know the amounts of bound proteins, the intensity of protein bands 
stained with Coomassie brilliant blue was quantified by densitometric s anning (Shimadzu, Model CS-930). The molar ratio of PTAC97 bound to 
PTAC58 indicated below each lane was estimated by dividing the intensity of protein bands with molecular mass of each protein. The results show 
that PTAC97 associates with PTAC58 in a l : 1 molar ratio. 
and a 90 kDa subunit [6,17], and karyopherin alpha and beta 
subunits [18] have been reported to mediate the pore-binding 
step of nuclear import. One of the PTAC components, 
PTAC58, was found to be the mouse homologue of the 60 kDa 
subunit of importin [7]. During the preparation of this manu- 
script, PTAC97, which reconstitutes the binding-step of import 
in conjunction with PTAC58, was found to be the mouse hom- 
ologue of karyopherin beta subunit [18] and the 90 kDa subunit 
C. 
- karyoph i le  + karyoph i le  
a .  b .  
of importin [17]. Since PTAC58 associates directly with T- 
bBSA, it is likely to be the bovine 54/56 kDa NLS-binding 
protein. The complex formation of the karyophile with 
PTAC58/PTAC97 complex reconstitutes the binding-step, indi- 
cating that PTAC97 appears to correspond to the bovine p97. 
In addition to these molecules, the 70 kDa heat-shock cognate 
protein [19-22], Ran/TC4 [23-25], and p 10 [26] have been func- 
tionally demonstrated to be involved in nuclear import, which 
, .  ' , t 
equator  sur face  
Fig+ 4. Nuclear binding of PTAC58/PTAC97 complex is induced in the presence of NLS-containing karyophile. Digitonin-permeabilized Ptk2 cells 
were incubated (on ice, 30 rain) with 12 pmol PTAC58 and HA epitope-tagged PTAC97 in the presence (panels b and c) or absence (panel a) of 6 
pmol T-APC. Cells fixed with 3.7% formaldehyde were permeabilized with 0.5% Triton X-100, incubated first with anti-HA epitope monoclonal 
antibody 12CA5 and then with FITC-conjugated goat antibodies to mouse IgG (TAGO) to visualize the localization of PTAC97. Panel c shows 
magnified images of the cell. Focusing on an equatorial plane through the nucleus reveals a discontinuous peripheral nuclear stain. This pattern 
appears to be more punctate when focusing on the upper surface of the nucleus. 
N. Imamoto et al./FEBS Letters 368 (1995) 415-419 
should act in concert with PTAC components in the mediated 
nuclear import process upon formation, pore-targeting, 
translocation, and/or dissociation of PTAC. 
A complex of T-bBSA and PTAC58 did not accumulate 
efficiently at the nuclear rim in the absence of PTAC97, indicat- 
ing tha~ PTAC97 contributes to the pore-binding process of 
PTAC. 'However, it is not yet clear whether PTAC97 possesses 
an NPC binding site. The mechanism for how a component(s) 
of NPC recognizes PTAC remains to be examined. One possi- 
bility is that a component(s) of NPC recognizes a higher order 
(stereospecific) structure of PTAC. Another is that association 
of NLS induces the conformational change of PTAC58/ 
PTAC97 complex which exposes an NPC binding site, present 
in primary structure of PTAC97 and/or PTAC58. Further stud- 
ies of the nature of the PTAC58/PTAC97 complex in the cyto- 
plasm of living cells, as well as how the association of a karyo- 
phile with PTAC58/PTAC97 triggers the nuclear pore-binding 
of PTAC in vivo are now in progress. 
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